Report

Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.

Asset 41 2
160 1608792 circle document icon png transparent png

Europe Radiopharmaceutical Theranostics Market Forecast to 2028 -Regional Analysis – by Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)

The Europe radiopharmaceutical theranostics market was valued at US$ 462.25 million in 2022 and is expected to reach US$ 853.61 million by 2028; it is estimated to register a CAGR of 10.8% from 2022 to 2028.

Rising Incidence of Cancer

The most common types of cancer are breast, lung, colon, rectum, and prostate. As people age, they become immunocompromised and often succumb to cancer risks. Poor lifestyles, longer working hours, increasingly stressful lives, smoking, alcohol consumption, contraceptive use, nulliparity, and reduced breastfeeding all contribute to breast cancer incidence.

Radiopharmaceutical theranostics have promising potential in cancer therapy. Theranostics is the combination of therapeutic and diagnostic techniques that utilize a suitable radiopharmaceutical agent. For example, radioiodine has a well-known theranostic application in diagnosing and treating differentiated thyroid cancer. Several radiopharmaceutical theranostic pairs are available for breast cancer applications. These pairs include 43/44 Sc/47 Sc, 64 Cu/67 Cu, 83 Sr/89 Sr, 86Y/90 Y, 110 In/111 In, 124I/131 I, 152 Tb/161 Tb, 152 Tb/149 Tb, 68 Ga/177 Lu, and 90 Y/177 Lu. 123 I/131 I is a well-known example of theranostic pair that is used in high-quality single-photon emission computerized tomography (SPECT)/CT for pre- and post-therapeutic assessment of thyroid cancer.

Malignant gliomas are deadly tumors with the availability of only a few therapeutic options. 89 Zr- and 177 Lu-labeled Lumi804-αCD11b is a promising theranostic technique intended for monitoring and reducing tumor-associated myeloid cells in gliomas and improving immunotherapy outcomes. Further, theranostics are incorporated in radiometals for positron emission tomography (PET) imaging and targeted radiopharmaceutical therapy (TRT). DOTA-octreotate (dotatate) radiolabeled with Lu-177 (177Lu-dotatate: Lutathera) or Ga-68 (68Ga-dotatate: NetSpot) are approved by the Food and Drug Administration (FDA) for TRT and PET imaging. Thus, a radiopharmaceutical theranostic approach has unprecedented value in diagnosing and treating different types of cancer, which fuels the overall market growth.

Europe Radiopharmaceutical Theranostics Market Overview

The Europe radiopharmaceutical theranostics market is segmented into the Germany, UK, France, Spain, Italy, and the Rest of Europe. Germany is expected to be among the largest contributors to the radiopharmaceutical theranostics market. The market growth in this region is due to the increasing incidences of chronic diseases such as cancer, diabetes, heart diseases, presence of supportive government plans, growing strategic initiatives by the market players, and development of innovative radiotherapies.

Exhibit: Europe Radiopharmaceutical Theranostics Market Revenue and Forecast to 2028 (US$ Million)

Europe Radiopharmaceutical Theranostics Market Segmentation

The Europe radiopharmaceutical theranostics market is segmented into product type, radioisotype, source, application, indication, end user, and country. Based on product type, the Europe radiopharmaceutical theranostics market is segmented into alpha emitters, beta emitters, and positron emission tomography (PET) tracers. The PET tracers segment held the largest market share in 2022.

Based on radioisotype, the Europe radiopharmaceutical theranostics market is segmented into technetium-99, gallium-68, iodine-131, iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and others. The Lutetium (Lu) 177 segment held the largest market share in 2022.

Based on source, the Europe radiopharmaceutical theranostics market is bifurcated into nuclear reactors and cyclotrons. The cyclotrons segment held a larger market share in 2022.

Based on application, the Europe radiopharmaceutical theranostics market is bifurcated into targeted therapeutic (Rx) and Companion Diagnostic (CDx). The targeted therapeutic (Rx) segment held a larger market share in 2022.

Based on indication, the Europe radiopharmaceutical theranostics market is segmented into oncology, cardiology, neurology, and others. The oncology segment held the largest market share in 2022.

Based on end user, the Europe radiopharmaceutical theranostics market is segmented into hospitals, diagnostic imaging centers, academic and research institutes, and others. The oncology segment held the largest market share in 2022.

Based on country, the Europe radiopharmaceutical theranostics market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe radiopharmaceutical theranostics market share in 2022.

Bayer AG, GE Healthcare Technologies Inc., Curium, Lantheus Medical Imaging, Inc., Telix Pharmaceuticals Ltd., Cardinal Health Inc., Advanced Accelerator Applications S.A, and Theragnostics are among the leading companies operating in the Europe radiopharmaceutical theranostics market.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Radiopharmaceutical Theranostics Market – by Product Type
1.3.2 Europe Radiopharmaceutical Theranostics Market – by Radioisotope
1.3.3 Europe Radiopharmaceutical Theranostics Market – by Source
1.3.4 Europe Radiopharmaceutical Theranostics Market – by Application
1.3.5 Europe Radiopharmaceutical Theranostics Market – by Indication
1.3.6 Europe Radiopharmaceutical Theranostics Market – by End User
1.3.7 Europe Radiopharmaceutical Theranostics Market – by Country
2. Radiopharmaceutical Theranostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Radiopharmaceutical Theranostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
4.3 Expert’s Opinion
5. Europe Radiopharmaceutical Theranostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Cancer
5.1.2 Rising Application in Treatment of Cardiovascular Disorders
5.2 Market Restraints
5.2.1 Regulatory Challenges for Approval of Radiopharmaceutical Theranostics
5.3 Market Opportunities
5.3.1 Theranostic Digital Twins for Personalized Radiopharmaceutical Therapies
5.4 Future Trends
5.4.1 Radiopharmaceutical Theranostics in Nuclear Medicine
5.5 Impact Analysis
6. Radiopharmaceutical Theranostics Market – Europe Analysis
6.1 Europe Radiopharmaceutical Theranostics Market Revenue Forecast and Analysis
7. Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 – by Product Type
7.1 Overview
7.2 Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)
7.2.1 Positron Emission Tomography (PET) Tracers
7.2.1.1 Overview
7.2.1.2 Positron Emission Tomography (PET) Tracers: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
7.2.2 Beta Emitters
7.2.2.1 Overview
7.2.2.2 Beta Emitters: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
7.2.3 Alpha Emitters
7.2.3.1 Overview
7.2.3.2 Alpha Emitters: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Radiopharmaceutical Theranostics Market Analysis – by Radioisotope
8.1 Overview
8.2 Radiopharmaceutical Theranostics Market Revenue Share, by Radioisotope 2021 & 2028 (%)
8.2.1 Technetium-99
8.2.1.1 Overview
8.2.1.2 Technetium-99: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.2 Gallium-68
8.2.2.1 Overview
8.2.2.2 Gallium-68: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.3 Iodine-131
8.2.3.1 Overview
8.2.3.2 Iodine-131: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.4 Iodine-123
8.2.4.1 Overview
8.2.4.2 Iodine-123: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.5 Fluorine-18 (18F)
8.2.5.1 Overview
8.2.5.2 Fluorine-18 (18F): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.6 Yttrium 90 (Y-90)
8.2.6.1 Overview
8.2.6.2 Yttrium 90 (Y-90): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.7 Lutetium (LU) 177
8.2.7.1 Overview
8.2.7.2 Lutetium (LU) 177: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.8 Copper (CU) 67
8.2.8.1 Overview
8.2.8.2 Copper (CU) 67: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.9 Copper (CU) 64
8.2.9.1 Overview
8.2.9.2 Copper (CU) 64: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.10 Others
8.2.10.1 Overview
8.2.10.2 Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Radiopharmaceutical Theranostics Market Analysis – by Source
9.1 Overview
9.2 Radiopharmaceutical Theranostics Market Revenue Share, by Source 2021 & 2028 (%)
9.2.1 Nuclear Reactors
9.2.1.1 Overview
9.2.1.2 Nuclear Reactors: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.2 Cyclotrons
9.2.2.1 Overview
9.2.2.2 Cyclotrons: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Radiopharmaceutical Theranostics Market Analysis – by Application
10.1 Overview
10.2 Radiopharmaceutical Theranostics Market Revenue Share, by Application 2021 & 2028 (%)
10.2.1 Targeted Therapeutic (Rx)
10.2.1.1 Overview
10.2.1.2 Targeted Therapeutics (Rx): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.2 Companion Diagnostic (CDx)
10.2.2.1 Overview
10.2.2.2 Companion Diagnostics (CDx): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
11. Europe Radiopharmaceutical Theranostics Market Analysis – by Indication
11.1 Overview
11.2 Radiopharmaceutical Theranostics Market Revenue Share, by Indication 2021 & 2028 (%)
11.2.1 Oncology
11.2.1.1 Overview
11.2.1.2 Oncology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
11.2.2 Neurology
11.2.2.1 Overview
11.2.2.2 Neurology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
11.2.3 Cardiology
11.2.3.1 Overview
11.2.3.2 Cardiology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
11.2.4 Others
11.2.4.1 Overview
11.2.4.2 Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
12. Europe Radiopharmaceutical Theranostics Market Analysis – by End User
12.1 Overview
12.2 Radiopharmaceutical Theranostics Market Revenue Share, by End User 2021 & 2028 (%)
12.2.1 Hospitals
12.2.1.1 Overview
12.2.1.2 Hospitals: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
12.2.2 Diagnostic Imaging Centers
12.2.2.1 Overview
12.2.2.2 Diagnostic Imaging Centers: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
12.2.3 Academic & Research Institutes
12.2.3.1 Overview
12.2.3.2 Academic & Research Institutes: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
12.2.4 Others
12.2.4.1 Overview
12.2.4.2 Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13. Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 – by Country Analysis
13.1 Europe: Radiopharmaceutical Theranostics Market
13.1.1 Overview
13.1.2 Europe: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
13.1.2.1 Germany: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.1 Overview
13.1.2.1.2 Germany Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.3 Germany Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.1.2.1.4 Germany Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.1.2.1.5 Germany Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.1.2.1.6 Germany Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.1.2.1.7 Germany Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.1.2.1.8 Germany Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.1.2.2 United Kingdom: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.1 Overview
13.1.2.2.2 United Kingdom Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.3 United Kingdom Radiopharmaceutical Theranostics Market, by Product type, 2019-2028 (US$ Million)
13.1.2.2.4 United Kingdom Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.1.2.2.5 United Kingdom Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.1.2.2.6 United Kingdom Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.1.2.2.7 United Kingdom Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.1.2.2.8 United Kingdom Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.1.2.3 France: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.1 Overview
13.1.2.3.2 France Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.3 France Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.1.2.3.4 France Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.1.2.3.5 France Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.1.2.3.6 France Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.1.2.3.7 France Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.1.2.3.8 France Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.1.2.4 Italy: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.1 Overview
13.1.2.4.2 Italy Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.3 Italy Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.1.2.4.4 Italy Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.1.2.4.5 Italy Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.1.2.4.6 Italy Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.1.2.4.7 Italy Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.1.2.4.8 Italy Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.1.2.5 Spain: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.1 Overview
13.1.2.5.2 Spain Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.3 Spain Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.1.2.5.4 Spain Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.1.2.5.5 Spain Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.1.2.5.6 Spain Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.1.2.5.7 Spain Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.1.2.5.8 Spain Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.1.2.6 Rest of Europe: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.1 Overview
13.1.2.6.2 Rest of Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.3 Rest of Europe Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.1.2.6.4 Rest of Europe Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.1.2.6.5 Rest of Europe Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.1.2.6.6 Rest of Europe Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.1.2.6.7 Rest of Europe Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.1.2.6.8 Rest of Europe Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
14. Radiopharmaceutical Theranostics Market – Industry Landscape
14.1 Overview
14.2 Growth Strategies in the Radiopharmaceutical Theranostics Market
14.3 Inorganic Growth Strategies
14.3.1 Overview
14.4 Organic Growth Strategies
14.4.1 Overview
15. Company Profiles
15.1 Bayer AG
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 GE HealthCare Technologies Inc
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Curium
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Lantheus Medical Imaging, Inc.
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Telix Pharmaceuticals Ltd.
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Cardinal Health Inc
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Advanced Accelerator Applications S.A.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Theragnostics
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. United Kingdom Radiopharmaceutical Theranostics Market, by Product type – Revenue and Forecast to 2028 (US$ Million)
Table 8. United Kingdom Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 9. United Kingdom Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 10. United Kingdom Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 11. United Kingdom Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 12. United Kingdom Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. France Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. France Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 15. France Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 16. France Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 17. France Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 18. France Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 19. Italy Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Italy Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 21. Italy Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 22. Italy Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 23. Italy Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 24. Italy Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Spain Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. Spain Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 27. Spain Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 28. Spain Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 34. Rest of Europe Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 35. Rest of Europe Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of Europe Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 37. Recent Inorganic Growth Strategies in the Radiopharmaceutical Theranostics Market
Table 38. Recent Organic Growth Strategies in the Radiopharmaceutical Theranostics Market
Table 39. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Radiopharmaceutical Theranostics Market Segmentation
Figure 2. Europe Radiopharmaceutical Theranostics Market, by Country
Figure 3. Europe Radiopharmaceutical Theranostics Market Overview
Figure 4. Positron Emission Tomography (PET) Tracers Segment Held Largest Share of Product Type Segment in Radiopharmaceutical Theranostics Market
Figure 5. Germany Expected to Show Remarkable Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Europe Experts’ Opinion
Figure 8. Europe Radiopharmaceutical Theranostics Market: Impact Analysis of Drivers and Restraints
Figure 9. Europe Radiopharmaceutical Theranostics Market – Revenue Forecast and Analysis – 2020-2028
Figure 10. Europe Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)
Figure 11. Positron Emission Tomography (PET) Tracers: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Beta Emitters: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Alpha Emitters: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Radiopharmaceutical Theranostics Market, by Radioisotope, 2021 & 2028 (%)
Figure 15. Technetium-99: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Gallium-68: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Iodine-131: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Iodine-123: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Fluorine-18 (18F): Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Yttrium 90 (Y-90): Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Lutetium (LU) 177: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Copper (CU) 67: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Copper (CU) 64: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Europe Radiopharmaceutical Theranostics Market, by Source, 2021 & 2028 (%)
Figure 26. Nuclear Reactors: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Cyclotrons: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Europe Radiopharmaceutical Theranostics Market, by Application, 2021 & 2028 (%)
Figure 29. Targeted Therapeutics (Rx): Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Companion Diagnostics (CDx): Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Europe Radiopharmaceutical Theranostics Market, by Indication, 2021 & 2028 (%)
Figure 32. Oncology: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Neurology: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Cardiology: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Others: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Europe Radiopharmaceutical Theranostics Market, by End User, 2021 & 2028 (%)
Figure 37. Hospitals: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Diagnostic Imaging Centers: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Academic & Research Institutes: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Others: Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Europe: Radiopharmaceutical Theranostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 42. Europe: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
Figure 43. Germany Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. United Kingdom Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. France Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Italy Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Spain Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Rest of Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Growth Strategies in the Radiopharmaceutical Theranostics Market

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe radiopharmaceutical theranostics market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the Europe radiopharmaceutical theranostics market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe radiopharmaceutical theranostics market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – Europe Radiopharmaceutical Theranostics Market

● Bayer AG
● GE Healthcare Technologies Inc.
● Curium
● Lantheus Medical Imaging, Inc.
● Telix Pharmaceuticals Ltd.
● Cardinal Health Inc.
● Advanced Accelerator Applications S.A
● Theragnostics

Pricing

$3,000.00$5,000.00

Have a Query?

Have a Question?

Related Reports

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

GET FREE SAMPLE PDF

× Enquire Now